On November 3, 2009, Acorda Therapeutics, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2009. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K, and incorporated by reference into this Item 2.02.
Item 9.01 Financial Statements and Exhibits
99.1 Press Release dated November 3, 2009.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Acorda Therapeutics, Inc. |
|
|
|
|
|
|
November 3, 2009 |
By: |
/s/ David Lawrence |
|
|
|
|
|
|
|
Name: David Lawrence |
|
|
|
Title: Chief Financial Officer |
Exhibit Index
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated November 3, 2009 |